Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration

By Westerlund Nina   Zdrojewska Justyna   Courtney Michael J   Coffey Eleanor T  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite

c-Jun N-terminal kinases as potential therapeutic targets

By Salh Baljinder  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1339-1353

Informa Healthcare

Access to resources Recommend Favorite

Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase

By Palin K.   McCusker R.   Strle K.   Moos F.   Dantzer R.   Kelley K.  

Psychopharmacology, Vol. 197, Iss. 4, 2008-05 ,pp. : 629-635

Springer Publishing Company

Access to resources Recommend Favorite

Hydrogen peroxide inhibits the immune response to lipopolysaccharide by attenuating signaling through c-Jun N-terminal kinase and p38 associated with protein kinase C

By Lee M.   Yea S.S.  

Immunopharmacology, Vol. 48, Iss. 2, 2000-07 ,pp. : 165-172

Elsevier

Access to resources Recommend Favorite

Inhibitors of c-jun-N-Terminal Kinase (JNK)

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-07 ,pp. : 755-766

Bentham Science Publishers

Access to resources Recommend Favorite